The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Henry Schein beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded significantly and GAAP earnings per share improved.
Gross margins shrank, operating margins were steady, net margins dropped.
Henry Schein tallied revenue of $2.34 billion. The 12 analysts polled by S&P Capital IQ expected sales of $2.22 billion on the same basis. GAAP reported sales were 16% higher than the prior-year quarter's $2.02 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $1.15. The 16 earnings estimates compiled by S&P Capital IQ anticipated $1.12 per share. GAAP EPS of $1.15 for Q4 were 15% higher than the prior-year quarter's $1.00 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 27.9%, 50 basis points worse than the prior-year quarter. Operating margin was 7.0%, about the same as the prior-year quarter. Net margin was 4.5%, 10 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $2.04 billion. On the bottom line, the average EPS estimate is $0.91.
Next year's average estimate for revenue is $8.78 billion. The average EPS estimate is $4.32.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 92 members out of 100 rating the stock outperform, and eight members rating it underperform. Among 32 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 31 give Henry Schein a green thumbs-up, and one gives it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Henry Schein is hold, with an average price target of $71.82.
If you're interested in health-care stocks like Henry Schein, you might want to expand your horizons to find maximum returns. Follow the money and meet a prime candidate for major returns in our new report, "Discover the Next Rule-Breaking Multibagger." Click here for instant access to this free report.
- Add Henry Schein to My Watchlist.